de Mendoza C - Search Results

1

Treatment of hepatitis delta and HIV infection.

Soriano V, de Mendoza C, Treviño A, Ramos-Rincón JM, Moreno-Torres V, Corral O, Barreiro P. Soriano V, et al. Among authors: de mendoza c. Liver Int. 2022 Jun 24. doi: 10.1111/liv.15345. Online ahead of print. Liver Int. 2022. PMID: 35748639 Review.

2

False positives for HIV using commercial viral load quantification assays.

de Mendoza C, Holguín A, Soriano V. de Mendoza C, et al. AIDS. 1998 Oct 22;12(15):2076-7. doi: 10.1097/00002030-199815000-00022. AIDS. 1998. PMID: 9814879 No abstract available.

3

Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.

Holguín A, de Mendoza C, Soriano V. Holguín A, et al. Among authors: de mendoza c. Eur J Clin Microbiol Infect Dis. 1999 Apr;18(4):256-9. doi: 10.1007/s100960050273. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10385013

4

Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors.

de Mendoza C, Soriano V, González-Lahoz J. de Mendoza C, et al. Eur J Clin Microbiol Infect Dis. 1999 Aug;18(8):604-5. doi: 10.1007/s100960050358. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10517203 No abstract available.

5

Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy.

Barreiro P, de Mendoza C, Soriano V, González-Lahoz J. Barreiro P, et al. Among authors: de mendoza c. AIDS. 2000 Jan 28;14(2):207-8. doi: 10.1097/00002030-200001280-00020. AIDS. 2000. PMID: 10708295 No abstract available.

6

Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodés B, Casas E, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 1999 Nov-Dec;2(6):344-9. J Hum Virol. 1999. PMID: 10774551

7

Emergence of zidovudine resistance in HIV-infected patients receiving stavudine.

de Mendoza C, Soriano V, Briones C, Gallego O, Barreiro P, Alvarez A, González-Lahoz J. de Mendoza C, et al. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):279-81. doi: 10.1097/00126334-200003010-00013. J Acquir Immune Defic Syndr. 2000. PMID: 10839665 No abstract available.

8

Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodríguez-Rosado R, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 2000 Nov-Dec;3(6):335-40. J Hum Virol. 2000. PMID: 11100914 Clinical Trial.

9

Monthly cyclic therapy in heavily pretreated HIV-infected patients.

Soriano V, Barreiro P, de Mendoza C, Dona C, González-Lahoz J. Soriano V, et al. Among authors: de mendoza c. AIDS Patient Care STDS. 2001 Apr;15(4):177-9. doi: 10.1089/10872910151133666. AIDS Patient Care STDS. 2001. PMID: 11359658 No abstract available.

10

Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays.

de Mendoza C, Lu W, Machuca A, Sainz M, Castilla J, Soriano V. de Mendoza C, et al. J Med Virol. 2001 Jul;64(3):217-22. doi: 10.1002/jmv.1039. J Med Virol. 2001. PMID: 11424107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page